Co-delivery of Doxorubicin and Afatinib with pH-responsive Polymeric Nanovesicle for Enhanced Lung Cancer Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-delivery of Doxorubicin and Afatinib with pH-responsive Polymeric Nanovesicle for Enhanced Lung Cancer Therapy

Published:2019-06-04 Issue:12 Volume:37 Page:1224-1233
ISSN:0256-7679
Container-title:Chinese Journal of Polymer Science
language:en
Short-container-title:Chin J Polym Sci

Author:

Gong Heng-Ye,Chen Yan-Gui,Yu Xing-Su,Xiao Hong,Xiao Jin-Peng,Wang Yong,Shuai Xin-Tao

Publisher

Springer Science and Business Media LLC

Subject

Polymers and Plastics,Organic Chemistry,General Chemical Engineering

Link

http://link.springer.com/content/pdf/10.1007/s10118-019-2272-6.pdf

Reference35 articles.

1. Bray, F.; Ferlay, J.; Soerjomataram I.; Siegel, R. L.; Torre, L. A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.2018, 68, 394–424.

2. Pesch, B. Cigarette smoking and lung cancerjrelative risk estimates for the major histological types from a pooled analysis of case—control studies. Int. J. Cancer.2012, 131, 1210–1219.

3. Lara, M. S.; Brunson, A.; Wun, T.; Tomlinson, B.; Qi, L.; Cress, R.; Gandara, D. R.; Kelly, K. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): A California cancer registry analysis. Lung Cancer2014, 85, 264–269.

4. Fennell, D. A.; Summers, Y.; Cadranel, J.; Benepal, T.; Christoph, D. C.; Lal, R.; Das, M.; Maxwell, F.; Visseren-Grul, C.; Ferry, D. Cisplatin in the modern era: The backbone of firstline chemotherapy for non-small cell lung cancer. Cancer Treat. Rev.2016, 44, 42–50.

5. Schuler, M.; Wu, Y. L.; Hirsh, V.; O’Byrne, K.; Yamamoto, N.; Mok, T.; Popat, S.; Sequist, L. V.; Massey, D.; Zazulina, V.; Yang, J. C. First-line afatinib versus chemotherapy in patients with non-small cell lung cancer and common epidermal growth factor receptor gene mutations and brain metastases. J. Thorac. Oncol.2016, 11, 380–390.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

2. Preparation of acid-sensitive polymeric oncology drug carriers and analysis of effectiveness;Nanomaterials and Energy;2023-10-01

3. Synthesis of polyethylene glycol gel-modified gold nanoparticles for targeted tumor therapy and correlation with the physiological environment;AIP Advances;2023-09-01

4. Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy;Molecular Pharmaceutics;2023-01-02

5. Polyurethane scaffold-based 3D lung cancer model recapitulates in vivo tumor biological behavior for nanoparticulate drug screening;Regenerative Biomaterials;2023-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3